The TACR1 gene gives cells instructions for a receptor that responds to substance P, a chemical messenger involved in pain, nausea, stress, and inflammation. If this receptor does not work normally, signaling in the brain and other tissues can change, which may affect pain sensitivity, vomiting, or stress symptoms. This gene can play a role in how your body responds to nausea and stress, and it is also studied in mood and addiction research. In medicine, this pathway is best known because drugs that block it can help control nausea.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the working parts of cells. Others mainly help determine when, where, and how strongly certain processes take place. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
TACR1Gene function
What if the gene works
The TACR1 gene makes a receptor for substance P, a signaling molecule. It helps nerve cells and other tissues manage pain, nausea, inflammation, and stress responses.
Risk
What if the gene does not work
Changes in the TACR1 gene can range from milder to more severe variants. These may reduce how well cells sense substance P, weakening receptor signaling and related nerve and immune cell communication.
Treatment
What does that mean for your treatment
No TACR1-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the TACR1 gene. TACR1 is an active drug target, and NK1 receptor blockers such as aprepitant are used for some forms of nausea, but their use is not guided by inherited variants in the TACR1 gene.
Gene function
What if the gene works
The TACR1 gene helps your brain, nerves, and some other tissues respond to substance P, a chemical messenger used in many body signals. This signaling shapes everyday functions such as sensing pain, triggering nausea and vomiting, and passing messages between nerve cells. Understanding how the TACR1 gene affects pain signaling also helps explain why it matters in normal body function.
The TACR1 gene provides instructions for a cell surface receptor that recognizes substance P, a common body messenger. Once substance P attaches, the receptor starts internal signals that tell the cell how to respond.
In pain pathways, this receptor helps pass messages from irritated or injured tissue toward the spinal cord and brain. It supports normal pain perception, which helps the body notice and react to potential harm.
In brain areas that control vomiting, TACR1 signaling helps coordinate nausea and the vomiting reflex. This is part of the body’s normal defense system for clearing harmful substances.
TACR1 activity also helps certain nerve cells tune how strongly they send and receive signals. This supports smooth communication between cells during everyday sensory and protective responses.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help shape normal human variation, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TACR1 gene can change the shape, stability, or cell surface placement of its receptor, which may weaken how it binds substance P and passes signals into the cell. In plain terms, this is how TACR1 gene variants affect receptor signaling. Some changes are mild and only partly reduce signaling, while more severe variants can sharply lower receptor activity or keep little of the receptor from reaching the cell surface.
How variants are linked to conditions
The TACR1 gene does not yet have a broadly confirmed link to a specific health condition, although research on TACR1 gene variants linked to health conditions is still developing. If you have a confirmed variant in the TACR1 gene, your doctor or genetic counselor can explain what it may mean in the context of your own health and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to TACR1. If you have concerns about how TACR1 may relate to your personal or family history, speaking with a doctor or genetic counselor can help put it in context.
Inheritance of TACR1 variants
There is not yet a broadly confirmed Mendelian pattern for how TACR1 gene variants are inherited in relation to a specific TACR1-related condition, because this gene is mainly studied for possible risk effects rather than a single inherited syndrome. Current evidence does not support describing TACR1 as clearly autosomal dominant, autosomal recessive, or X linked. For families asking how TACR1 gene variants are inherited, TACR1 is located on chromosome 2, which is an autosome, so each person inherits one copy from each parent.
What does my TACR1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for the TACR1 gene, though this can change as research grows. If you have a TACR1 result and want to understand what it could mean for your relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
TACR1 genetic testing uses a blood sample, saliva, or cheek swab to read the TACR1 gene and look for variants. A lab compares your DNA sequence with a standard reference to identify changes. Results may show a benign variant, a variant of uncertain significance, or a variant linked to a health condition.
When should I consider getting a genetic test?
There is not yet a broadly established TACR1-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, symptoms, and family history, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines, so the same treatment may work differently from one person to another. Some people break down a drug faster or slower, while others may be more or less sensitive to its effects. These differences are common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medication. It studies connections between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This understanding can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the TACR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Seek medical advice if you have unexpected side effects, a medicine is not working as expected, or you have questions about how your health history may affect treatment.
History
Research on the TACR1 gene grew out of decades of work on substance P, a signaling molecule identified in the 1930s and studied closely in the second half of the 20th century. In the early 1990s, scientists cloned the gene and linked it to the neurokinin 1 receptor, giving researchers a clear genetic target to study. Building on this early work, scientists uncovered more about the gene. That progress helped drive the development of NK1 receptor blocking medicines, including drugs later used to reduce nausea and vomiting during chemotherapy. TACR1 also became part of psychiatric and pain research as interest expanded from the lab into everyday clinical questions. Over time, its history has reflected a broader shift from basic nerve signaling research to targeted drug development.